Veterinary
Pharmaceutical
Consultants
Veterinary consultants with industry, clinical, research, academic, and start-up experience that can provide comprehensive guidance from concept to commercialization
About our Veterinary Consultants
Comprehensive services: Our veterinary consultants provide a range of animal health consulting services including technology assessment, forecasting, financial modeling, veterinary clinical studies, development planning, budgets, and licensing and commercial strategy. We have worked with a broad range of clients including human biopharmaceutical companies, veterinary companies, veterinary labs, medical device companies, veterinary contract research organizations, universities, and investors.
Comprehensive expertise and experience: Our veterinary consulting team’s careers span industry, academia and clinical practice with expertise in surgery, medicine, product development, and commercialization of veterinary products. In addition, we have a deep understanding of veterinary regulations (FDA, USDA), designing and managing veterinary clinical studies, and partnering with veterinary companies and veterinary distributors.
Animal Health Consulting Services
Veterinary Clinical Studies
We have extensive experience as study investigators, developing veterinary study protocols and documentation, and managing pilot and pivotal veterinary clinical trials (e.g., veterinary clinical studies). Veterinary clinical studies give pets access to new veterinary therapeutics while gathering valuable data to advance human and veterinary medicine. Dr. Woods has experience in both human and veterinary clinical research and our veterinary clinical studies are developed and performed similar to human clinical studies.
Veterinary Regulatory Consulting
Our team can support veterinary regulatory affairs and submissions for veterinary drugs (21 CFR), veterinary biologics and veterinary diagnostics (9 CFR), and other regulated veterinary products. We can assist clients in preparing and submitting product development plans, INADs, production outlines, blueprints, and other documents to the FDA-Center for Veterinary Medicine and USDA-Center for Veterinary Biologics, as well as serving as regulatory liaisons and responsible officials for third parties.
Animal Health Business Development
Our veterinary consultants can perform veterinary market research and competitive analysis, veterinary sales forecasting, and create financial models that incorporate R&D, regulatory fees and other expenditures related to veterinary product development. We can also create product development plans and commercialization strategies, and assist with veterinary company formation and interim management. Our animal health consultants have negotiated a range of agreements with veterinary companies and veterinary distributors including option, license, material transfer, and manufacturing agreements.
Veterinary Research: basic research and bioinformatics
Through our network, we can provide large scale data analysis including cleaning, biostatistics, advanced data analytics, visualization, and interactive web-based tool development using natural language processing (NLP), R, Python and other programming languages for a customized approach to analyzing large datasets. We can also support and coordinate a range of specialized testing of biospecimens including multi-omics (genomics through protemics), pharmacokinetic method development, cell based assays and a range of other laboratory based research with our academic and private sector collaborators.
Founder and Principal Consultant
Craig Woods DVM, MS, MBA established Woods Consulting, LLC (Animal Health Consultants) in 2007, which has supported dozens of domestic and international companies in advancing their products into the animal health market. Craig is one of the few veterinarians with expertise in human clinical research (Phase II-III) which has augmented his approach to veterinary clinical studies. Dr. Woods has led the development of antivenoms, immunotherapeutics, orthopedic and intraocular implants and other drugs, devices and diagnostics for applications in human and veterinary medicine. Between 1998-2015, Craig held senior level business development and research positions in the veterinary industry, leading the due diligence on dozens of technology licensing transactions and supporting product commercialization. In 2015, he was recruited into academia to lead human and veterinary clinical research, most recently serving as the Director of Infectious Disease and Biosecurity Projects at Arizona State University’s Complex Adaptive Systems Initiative. He is a licensed veterinarian and received his BS, DVM, and MS from the University of Missouri and an MBA from ASU.
Recent Animal Health Regulatory Updates
Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Comment Request (January 7, 2025; 90 FR 1157)
Charter for the Jurisdiction Determination Process of the USDA CVB/FDA CVM Jurisdiction Committee (December 2024)
Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2025 (July 31, 2024; 89 FR 61459)